CADAMURO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 6.083
EU - Europa 2.778
AS - Asia 1.634
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 8
SA - Sud America 7
OC - Oceania 6
Totale 10.528
Nazione #
US - Stati Uniti d'America 5.983
CN - Cina 661
IT - Italia 531
SG - Singapore 482
IE - Irlanda 439
SE - Svezia 423
DE - Germania 390
RU - Federazione Russa 340
HK - Hong Kong 267
UA - Ucraina 248
GB - Regno Unito 162
CA - Canada 97
FI - Finlandia 84
IN - India 52
FR - Francia 37
TR - Turchia 35
ID - Indonesia 30
DK - Danimarca 29
VN - Vietnam 27
JP - Giappone 23
BE - Belgio 17
AT - Austria 16
NL - Olanda 15
EU - Europa 12
TW - Taiwan 11
KR - Corea 10
ES - Italia 9
IR - Iran 9
NO - Norvegia 9
PK - Pakistan 8
CZ - Repubblica Ceca 7
CH - Svizzera 6
IL - Israele 6
PL - Polonia 5
RO - Romania 5
NZ - Nuova Zelanda 4
PH - Filippine 4
BG - Bulgaria 3
BR - Brasile 3
CO - Colombia 3
IQ - Iraq 3
MY - Malesia 3
NG - Nigeria 3
AU - Australia 2
GR - Grecia 2
MX - Messico 2
TN - Tunisia 2
AM - Armenia 1
BY - Bielorussia 1
CL - Cile 1
EG - Egitto 1
MA - Marocco 1
PA - Panama 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
Totale 10.528
Città #
Ann Arbor 989
Fairfield 568
Woodbridge 545
Chandler 457
Houston 438
Dublin 424
Singapore 414
Ashburn 325
Frankfurt am Main 286
Wilmington 278
Jacksonville 269
Seattle 246
Hong Kong 245
New York 234
Dearborn 224
Cambridge 181
Milan 156
Princeton 145
Nanjing 104
Santa Clara 98
Shanghai 77
Lawrence 54
Guangzhou 49
Beijing 47
Lachine 46
Hangzhou 45
Altamura 37
Boardman 33
Shenyang 32
Helsinki 31
San Diego 31
Jakarta 28
Andover 27
Rome 24
Nanchang 23
Zhengzhou 20
Fremont 19
Ottawa 19
Padova 19
Kunming 18
Los Angeles 18
Pune 18
Brussels 17
Hebei 17
Changsha 16
Toronto 16
Tianjin 15
Mountain View 14
Auburn Hills 12
Dong Ket 12
Jiaxing 12
Jinan 12
London 12
Munich 11
Norwalk 10
Vienna 10
Cinisello Balsamo 9
Hefei 9
Lissone 9
Pisa 9
Redmond 9
Bonndorf 8
Chicago 8
Huizen 8
Kiev 8
New Haven 8
Ningbo 8
Tokyo 8
Washington 8
Appiano Gentile 7
Carate Brianza 7
Oslo 7
Taizhou 7
Assago 6
Brescia 6
Brno 6
Casalserugo 6
Central 6
Edmonton 6
Genoa 6
Monza 6
Udine 6
Xi'an 6
Bergamo 5
Falls Church 5
Foshan 5
Fuzhou 5
Lanzhou 5
Lappeenranta 5
Moscow 5
Saskatoon 5
Shenzhen 5
Tel Aviv 5
Atlanta 4
Auckland 4
Bari 4
Chengdu 4
Dongguan 4
Isola Della Scala 4
Kilburn 4
Totale 7.802
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 465
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 356
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 300
Nephrosphere-Derived Cells are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 293
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 211
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 197
null 197
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 194
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 178
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 176
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 175
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 172
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 171
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 170
Cholangiocyte biology as relevant to cystic liver diseases 168
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 167
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 164
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 161
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 158
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 156
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 155
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 155
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 152
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 147
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 147
Emerging concepts in biliary repair and fibrosis 146
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 145
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 145
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 142
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 141
Animal models of cholestasis: An update on inflammatory cholangiopathies 135
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 133
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 133
The Deleterious Interplay Between Tumor Epithelia and Stroma in Cholangiocarcinoma 133
Protein kinase a-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis 132
The patient presenting with isolated hyperbilirubinemia 131
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM. 131
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 127
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 124
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C 123
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 122
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 117
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 112
β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis 111
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation 111
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 110
Cxcl1 and cxcl10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 109
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 109
CXCL1 and CXCL10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 108
The healthy biliary tree: Cellular and immune biology 107
Role of angiogenesis and angiogenic factors for cholangiocyte growth 106
Notch signaling and progenitor/ductular reaction in steatohepatitis 105
Leukaemia Inhibitory Factor Protects Cholangiocarcinoma Cells From Cytotoxicity Via MCL-1 104
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 99
Oxidative Stress in Non-Autoimmune Liver Diseases 87
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 86
Animal models for cystic fibrosis liver disease (CFLD) 86
Leukaemia inhibitory factor protects cholangiocytes from cytotoxicity in cholangiocarcinoma 84
The multitasking behavior of cholangiocyte in the reaction to liver damage 81
RAC1 and CDC42 activation regulates pdgf‐d mediated caf recruitment by cancer cells in cholangiocarcinoma 79
Colestasi intraepatica 78
Cirrosi Biliare Primitiva 78
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 78
Animal models of cholangiocarcinoma: What they teach us about the human disease 78
Colangite Sclerosante Primitiva 76
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 68
Colestasi Genetiche 66
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 63
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts 61
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 54
Life without notch: Liver repair in Alagille syndrome 52
Tumor microenvironment and immunology of cholangiocarcinoma 47
Paracrine platelet-derived growth factor-d (pdgf-d) signaling mediates cancer-associated fibroblast recruitment in cholangiocarcinoma 40
Gender differences in repair mechanisms of chronic cholangiopathies with progressive fibrosis 39
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 37
Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes Lymphangiogenesis in Cholangiocarcinoma 35
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 35
The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit 35
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 34
CANCER ASSOCIATED FIBROBLASTS RECRUITMENT IS MEDIATED BY PLATELET-DERIVED GROWTH FACTOR (PDGF) SIGNALING IN CHOLANGIOCARCINOMA 33
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 31
Altered Jagged-1/Notch signalling influences liver repair mechanisms in Alagille syndrome 30
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 29
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 29
Inhibition of YAP activation induces cell senescence and autophagy while blocking cell proliferation in cholangiocarcinoma (CCA) 28
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 27
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease 27
Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia 27
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer 26
Cholangiocyte biology and pathobiology 24
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 24
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second-trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 24
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 24
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 24
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 24
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1−/− mouse model of congenital hepatic fibrosis 23
Liver Matrix in Benign and Malignant Biliary Tract Disease 23
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma 22
The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases 21
Cholangiocarcinoma 20
Totale 10.633
Categoria #
all - tutte 41.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.454 0 0 135 151 177 240 259 122 148 81 102 39
2020/20211.335 94 142 139 141 124 86 127 110 119 108 78 67
2021/2022722 52 69 92 45 27 50 31 37 36 67 85 131
2022/20231.670 167 501 166 161 118 240 26 89 100 12 45 45
2023/20242.104 76 70 68 131 351 467 355 103 223 19 39 202
2024/20251.106 275 535 296 0 0 0 0 0 0 0 0 0
Totale 11.100